Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

April 01, 2013; Volume 83,Issue 4

Special Issue In Memory Of Avram Goldstein

  • You have access
    Avram Goldstein: The Founder of Molecular Pharmacology
    Brian Cox, Ji-Sheng Han and Ray Dingledine
    Molecular Pharmacology April 2013, 83 (4) 720-722; DOI: https://doi.org/10.1124/mol.112.084640
  • You have access
    Recent Developments in the Study of Opioid Receptors
    Brian M. Cox
    Molecular Pharmacology April 2013, 83 (4) 723-728; DOI: https://doi.org/10.1124/mol.112.083279
  • You have access
    Dynorphin–Still an Extraordinarily Potent Opioid Peptide
    Charles Chavkin
    Molecular Pharmacology April 2013, 83 (4) 729-736; DOI: https://doi.org/10.1124/mol.112.083337
  • You have access
    Sex-Biased Stress Signaling: The Corticotropin-Releasing Factor Receptor as a Model
    Rita J. Valentino, Debra Bangasser and Elisabeth J. Van Bockstaele
    Molecular Pharmacology April 2013, 83 (4) 737-745; DOI: https://doi.org/10.1124/mol.112.083550
  • You have access
    Ionotropic Glutamate Receptors: Regulation by G-Protein-Coupled Receptors
    Asheebo Rojas and Raymond Dingledine
    Molecular Pharmacology April 2013, 83 (4) 746-752; DOI: https://doi.org/10.1124/mol.112.083352
  • You have access
    Nicotinic Receptors in Addiction Pathways
    Frances M. Leslie, Celina Y. Mojica and Daisy D. Reynaga
    Molecular Pharmacology April 2013, 83 (4) 753-758; DOI: https://doi.org/10.1124/mol.112.083659
  • You have access
    P2X Receptors as Drug Targets
    R. Alan North and Michael F. Jarvis
    Molecular Pharmacology April 2013, 83 (4) 759-769; DOI: https://doi.org/10.1124/mol.112.083758

Articles

  • You have access
    Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling
    Jessica L. Esseltine, Melinda D. Willard, Isabella H. Wulur, Mary E. Lajiness, Thomas D. Barber and Stephen S. G. Ferguson
    Molecular Pharmacology April 2013, 83 (4) 770-780; DOI: https://doi.org/10.1124/mol.112.081695
  • You have access
    Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
    Matthew Duvernay, Summer Young, David Gailani, Jonathan Schoenecker and Heidi E. Hamm
    Molecular Pharmacology April 2013, 83 (4) 781-792; DOI: https://doi.org/10.1124/mol.112.083477
  • You have access
    Inhibitors of PI(4,5)P2 Synthesis Reveal Dynamic Regulation of IgE Receptor Signaling by Phosphoinositides in RBL Mast Cells
    Marcela de Souza Santos, Rose Mary Zumstein Georgetto Naal, Barbara Baird and David Holowka
    Molecular Pharmacology April 2013, 83 (4) 793-804; DOI: https://doi.org/10.1124/mol.112.082834
  • You have access
    ICA-105574 Interacts with a Common Binding Site to Elicit Opposite Effects on Inactivation Gating of EAG and ERG Potassium Channels
    Vivek Garg, Anna Stary-Weinzinger and Michael C. Sanguinetti
    Molecular Pharmacology April 2013, 83 (4) 805-813; DOI: https://doi.org/10.1124/mol.112.084384
  • You have access
    Membrane Tethered Bursicon Constructs as Heterodimeric Modulators of the Drosophila G Protein–Coupled Receptor Rickets
    Benjamin N. Harwood, Jean-Philippe Fortin, Kevin Gao, Ci Chen, Martin Beinborn and Alan S. Kopin
    Molecular Pharmacology April 2013, 83 (4) 814-821; DOI: https://doi.org/10.1124/mol.112.081570
  • You have access
    Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
    Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos and Patrick M. Sexton
    Molecular Pharmacology April 2013, 83 (4) 822-834; DOI: https://doi.org/10.1124/mol.112.084525
  • You have access
    A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
    M. J. Noetzel, K. J. Gregory, P. N. Vinson, J. T. Manka, S. R. Stauffer, C. W. Lindsley, C. M. Niswender, Z. Xiang and P. J. Conn
    Molecular Pharmacology April 2013, 83 (4) 835-847; DOI: https://doi.org/10.1124/mol.112.082891
  • You have access
    Formation, Reactivity, and Antiplatelet Activity of Mixed Disulfide Conjugates of Clopidogrel
    Haoming Zhang, D. Adam Lauver, Benedict R. Lucchesi and Paul F. Hollenberg
    Molecular Pharmacology April 2013, 83 (4) 848-856; DOI: https://doi.org/10.1124/mol.112.084392
  • You have access
    Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
    Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
    Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743
  • You have access
    Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
    Juliana Akinaga, Vanessa Lima, Luiz Ricardo de Almeida Kiguti, Flávia Hebeler-Barbosa, Rocío Alcántara-Hernández, J. Adolfo García-Sáinz and André Sampaio Pupo
    Molecular Pharmacology April 2013, 83 (4) 870-881; DOI: https://doi.org/10.1124/mol.112.082313
  • You have access
    A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
    Katherine R. Singleton, Jihye Kim, Trista K. Hinz, Lindsay A. Marek, Matias Casás-Selves, Clark Hatheway, Aik Choon Tan, James DeGregori and Lynn E. Heasley
    Molecular Pharmacology April 2013, 83 (4) 882-893; DOI: https://doi.org/10.1124/mol.112.084111
  • You have access
    Phosphodiesterase 4 Inhibitors Augment the Ability of Formoterol to Enhance Glucocorticoid-Dependent Gene Transcription in Human Airway Epithelial Cells: A Novel Mechanism for the Clinical Efficacy of Roflumilast in Severe Chronic Obstructive Pulmonary Disease
    Thunicia Moodley, Sylvia M. Wilson, Taruna Joshi, Christopher F. Rider, Pawan Sharma, Dong Yan, Robert Newton and Mark A. Giembycz
    Molecular Pharmacology April 2013, 83 (4) 894-906; DOI: https://doi.org/10.1124/mol.112.083493
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 83 (4)
Molecular Pharmacology
Vol. 83, Issue 4
1 Apr 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Special Issue In Memory Of Avram Goldstein
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics